Preparation method of traditional Chinese medicine for treating osteoporosis

Abstract

The invention discloses a preparation method of a traditional Chinese medicine for treating osteoporosis. The preparation method comprises the following steps: weighing 15-23 parts of Psychotria Serpens, 14-20 parts of Chinese photinia leaf, 10-16 parts of Philippine flemingia root, 16-24 parts of radix achyranthis bidentatae, 17-23 parts of Thladiantha dubia, 13-19 parts of Semiliquidambar cathayensis, 18-24 parts of Chinese holly fruit, 16-22 parts of salvia chinensis, 10-16 parts of Streptopus obtusatus Fassett., 12-20 parts of Abelia biflora, 15-23 parts of phoenix hawksbeard root, 12-20 parts of Aralia echinocaulis and 15-19 parts of Sambucus thunbergiana; soaking all the above traditional Chinese medicine active pharmaceutical ingredients in clear water or pure water; adding the soaked traditional Chinese medicine active pharmaceutical ingredients in a decocting container, and decocting; and after the decocting process is completed, filtering out the liquor, wherein the obtained liquor is the medicine for oral administration. The traditional Chinese medicine disclosed by the invention is based on the understanding and treatment principles on the osteoporosis mechanism, is taken in a direct oral administration manner to realize reinforcement and elimination in combination, has the effects of reinforcing bones and muscles and treating rheumatism, and achieves the advantages of remarkable curative effect, easy quality control, favorable stability and basically no adverse effect.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a preparation method of traditional Chinese medicines for treating osteoporosis. Background technique [0002] Osteoporosis is mainly divided into primary and secondary. In addition to idiopathic, primary is divided into type I and type II. Type I, also known as postmenopausal osteoporosis, is a high conversion type. The main reason is For estrogen deficiency; type II, also known as senile osteoporosis, is a low conversion type, due to aging. Osteoporosis is caused by a variety of factors. Its basic pathological mechanism is the defect in the coupling of bone resorption and bone formation in the process of bone metabolism, which leads to the imbalance of calcium and phosphorus metabolism in the human body and the gradual decrease of bone density. Clinical symptoms. And it may cause osteoporotic fractures. Clinically, the drugs used to prevent and treat osteoporosis ...

AI Technical Summary

Problems solved by technology

Most of these drugs have a protective effect and enhance absorption, and their functions are not comprehensive enough to prevent and treat complications after osteoporosis, and they are prone to side effects, which is not conducive to health.